加斯德明D通过加速免疫血栓和死体炎症驱动着焦点晶体血栓性微血管病变

Kanako Watanabe-Kusunoki1,2, Chenyu Li1, Tâmisa Seeko Bandeira Honda1

  • 1Renal Division, Department of Medicine IV, Ludwig Maximilian University Hospital, Ludwig Maximilian University, Munich, Germany.

Blood
|April 24, 2024
PubMed
概括

加斯德明D (GSDMD) 通过促进中性粒细胞成熟和亡来驱动血栓性微血管病变 (TMA). 用迪苏尔菲拉姆抑制GSDMD在小鼠中受到TMA的保护,这表明GSDMD是治疗点.

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687